Aberrant signaling pathways regulating proliferation and differentiation of hematopoietic stem cells (HSCs) can contribute to disease pathogenesis and neoplastic growth. Phosphoinositides (PIs) are inositol phospholipids that are implicated in the regulation of critical signaling pathways: aberrant regulation of Phospholipase C (PLC) beta1, PLCgamma1 and the PI3K/Akt/mTOR pathway play essential roles in the pathogenesis of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML).
Advances in MDS/AML and inositide signalling / De Stefano A.; Marvi M.V.; Fazio A.; McCubrey J.A.; Suh P.G.; Ratti S.; Ramazzotti G.; Manzoli L.; Cocco L.; Follo M.Y.. - In: ADVANCES IN BIOLOGICAL REGULATION. - ISSN 2212-4926. - STAMPA. - 87:(2023), pp. 100955.1-100955.6. [10.1016/j.jbior.2023.100955]
Advances in MDS/AML and inositide signalling
De Stefano A.;Marvi M. V.;Fazio A.;Ratti S.;Ramazzotti G.;Manzoli L.;Cocco L.;Follo M. Y.
2023
Abstract
Aberrant signaling pathways regulating proliferation and differentiation of hematopoietic stem cells (HSCs) can contribute to disease pathogenesis and neoplastic growth. Phosphoinositides (PIs) are inositol phospholipids that are implicated in the regulation of critical signaling pathways: aberrant regulation of Phospholipase C (PLC) beta1, PLCgamma1 and the PI3K/Akt/mTOR pathway play essential roles in the pathogenesis of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
